GenTech Scientific LLC

GenTech Scientific LLC is a specialized provider focused on the sale and refurbishment of analytical laboratory instruments, serving a diverse clientele across various sectors including pharmaceuticals and environmental analysis. GenTech Scientific LLC, founded in 1996 in the US, specializes in the refurbishment and sale of used analytical laboratory instruments. The company was acquired by Lakelet Capital in September 2020, although financial terms were not disclosed. Clair Bragg serves as the CEO of the company.

GenTech Scientific specializes in the sale and refurbishment of used and certified analytical laboratory instruments. The company offers a wide range of equipment from leading manufacturers, such as Agilent, Shimadzu, Waters, and ThermoFisher. Their core services include the refurbishment of instruments to meet stringent operational standards, training for end-users to ensure proper equipment usage, and ongoing support and repairs. GenTech's target clientele encompasses various sectors, including research and testing laboratories in pharmaceuticals, environmental analysis, and educational institutions, allowing them to deliver precise and reliable data.

Geographically, GenTech serves a global market, providing their expertise and products to clients from North America to Europe and beyond. GenTech Scientific generates revenue primarily through direct sales of refurbished laboratory equipment, service contracts, and training programs tailored for their customers. The business model includes both B2B transactions with research laboratories, universities, and corporate clients, as well as options for service and repair agreements that ensure the longevity and performance of the instruments sold. The company’s pricing structure is built on competitive rates for individual refurbished products, along with service fees for repairs and maintenance contracts that offer ongoing support.

This multifaceted approach enables GenTech to establish long-term relationships with clients while ensuring a steady revenue stream through various service offerings and product sales. Looking ahead, GenTech Scientific plans to utilize recent funding to enhance its product offerings and expand into new geographical markets. The company is focusing on developing next-generation refurbished laboratory instruments with a target launch in the next 12 to 18 months. Additionally, they aim to penetrate markets in Asia and South America by 2022, leveraging their established reputation and expertise to attract new clients.

The acquisition by Lakelet Capital in September 2020 is expected to provide the necessary resources to support these initiatives.